63 related articles for article (PubMed ID: 6876436)
21. Expression of carcinoembryonic antigen and nonspecific cross-reacting 50-kDa antigen in human normal and cancerous colon mucosa: comparative ultrastructural study with monoclonal antibodies.
Baranov V; Yeung MM; Hammarström S
Cancer Res; 1994 Jun; 54(12):3305-14. PubMed ID: 8205554
[TBL] [Abstract][Full Text] [Related]
22. The C-type lectin MGL expressed by dendritic cells detects glycan changes on MUC1 in colon carcinoma.
Saeland E; van Vliet SJ; Bäckström M; van den Berg VC; Geijtenbeek TB; Meijer GA; van Kooyk Y
Cancer Immunol Immunother; 2007 Aug; 56(8):1225-36. PubMed ID: 17195076
[TBL] [Abstract][Full Text] [Related]
23. [Preparation and identification of monoclonal antibodies against different epitopes on TAG-72 antigen].
Xu M
Zhonghua Zhong Liu Za Zhi; 1993 Nov; 15(6):431-4. PubMed ID: 7515344
[TBL] [Abstract][Full Text] [Related]
24. Anti-alpha-galactosyl antibodies recognizing epitopes terminating with alpha1,4-linked galactose: human natural and mouse monoclonal anti-NOR and anti-P1 antibodies.
Duk M; Kusnierz-Alejska G; Korchagina EY; Bovin NV; Bochenek S; Lisowska E
Glycobiology; 2005 Feb; 15(2):109-18. PubMed ID: 15342552
[TBL] [Abstract][Full Text] [Related]
25. Molecular cloning of a human monoclonal antibody reactive to ganglioside GM3 antigen on human cancers.
Hoon DS; Wang Y; Sze L; Kanda H; Watanabe T; Morrison SL; Morton DL; Irie RF
Cancer Res; 1993 Nov; 53(21):5244-50. PubMed ID: 7916649
[TBL] [Abstract][Full Text] [Related]
26. The identification, isolation and characterization of a 67 kilodalton, PNA-reactive autoantigen commonly expressed in human adenocarcinomas.
Laderoute M; Willans D; Wegmann T; Longenecker M
Anticancer Res; 1994; 14(3B):1233-45. PubMed ID: 7520680
[TBL] [Abstract][Full Text] [Related]
27. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
Bodey B; Siegel SE; Kaiser HE
Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
[TBL] [Abstract][Full Text] [Related]
28. Cancer-related serological recognition of human colon cancer: identification of potential diagnostic and immunotherapeutic targets.
Scanlan MJ; Welt S; Gordon CM; Chen YT; Gure AO; Stockert E; Jungbluth AA; Ritter G; Jäger D; Jäger E; Knuth A; Old LJ
Cancer Res; 2002 Jul; 62(14):4041-7. PubMed ID: 12124339
[TBL] [Abstract][Full Text] [Related]
29. The prognostic value of immunofluorescence from oral swabs in patients with tonsillar carcinoma.
Mang WL; Hammer C
J Med; 1981; 12(6):447-53. PubMed ID: 7033427
[TBL] [Abstract][Full Text] [Related]
30. AgSK1, a novel carcinoma associated antigen.
Chang HR; Koda K; Chang S; Baird S
Cancer Res; 1993 Mar; 53(5):1122-7. PubMed ID: 8439957
[TBL] [Abstract][Full Text] [Related]
31. Improved detection of the early stages of colon cancer by determining both free circulating and immune complex-bound antigens reactive with monoclonal antibody.
Chester SJ; Lim YP; Vezeridis MP; Hixson DC
Cancer Res; 1994 Aug; 54(15):3974-8. PubMed ID: 8033125
[TBL] [Abstract][Full Text] [Related]
32. Gastrointestinal tumor markers, other than carcinoembryonic antigen, and alpha fetal protein.
Klavins JV
Cancer Detect Prev; 1983; 6(1-2):131-6. PubMed ID: 6883374
[TBL] [Abstract][Full Text] [Related]
33. Monoclonal antibodies to human lung tumor antigens demonstrated by immunofluorescence and immunoprecipitation.
Brenner BG; Jothy S; Shuster J; Fuks A
Cancer Res; 1982 Aug; 42(8):3187-92. PubMed ID: 7046919
[TBL] [Abstract][Full Text] [Related]
34. Two proliferation-related proteins, TYMS and PGK1, could be new cytotoxic T lymphocyte-directed tumor-associated antigens of HLA-A2+ colon cancer.
Shichijo S; Azuma K; Komatsu N; Ito M; Maeda Y; Ishihara Y; Itoh K
Clin Cancer Res; 2004 Sep; 10(17):5828-36. PubMed ID: 15355913
[TBL] [Abstract][Full Text] [Related]
35. Improved radioimmunotherapeutic efficacy of an anticarcinoma monoclonal antibody (131I-CC49) when given in combination with gamma-interferon.
Greiner JW; Ullmann CD; Nieroda C; Qi CF; Eggensperger D; Shimada S; Steinberg SM; Schlom J
Cancer Res; 1993 Feb; 53(3):600-8. PubMed ID: 8425194
[TBL] [Abstract][Full Text] [Related]
36. Anti-Tn human monoclonal antibodies generated following active immunization with partially desialylated ovine submaxillary mucin.
O'Boyle KP; Wright K
Hum Antibodies Hybridomas; 1994; 5(1-2):25-31. PubMed ID: 7532023
[TBL] [Abstract][Full Text] [Related]
37. [Neoplasm markers useful for diagnosis and monitoring of colonic neoplasms].
Ławicki S; Mroczko B; Szmitkowski M
Postepy Hig Med Dosw; 2002; 56(5):617-34. PubMed ID: 12596691
[TBL] [Abstract][Full Text] [Related]
38. Characterization of the colorectal antigen IOR C2.II.
Vázquez AM; Tormo B; Velandia A; Gómez CA; Alfonso M; Giscombe R; Ansotegui I; Jeddi-Tehrani M; Pérez R; Mellstedt H
Year Immunol; 1993; 7():137-45. PubMed ID: 7690506
[No Abstract] [Full Text] [Related]
39. Are matrix-immobilized neoglycoproteins, plant and human lectins and carbohydrate--binding antibodies from human serum mediators of adhesion in vitro for carcinoma and lymphosarcoma cells?
Wawotzny R; André S; Dong X; Joshi SS; Gabius HJ
Anticancer Res; 1995; 15(1):169-74. PubMed ID: 7733629
[TBL] [Abstract][Full Text] [Related]
40. The tumor association of a trisaccharide epitope: specificity of antiserum developed to galactose beta1->3 N-acetyl glucosamine beta1-->3 galactose.
Diakun KR; Vargas F; Tamburlin J
Immunol Invest; 1996 May; 25(3):253-66. PubMed ID: 8860696
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
